Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Different mutational characteristics of the subsets of EGFR-tyrosine kinase inhibitor sensitizing mutation-positive lung adenocarcinoma

Fig. 2

Mutational pattern of study cohort. Box plot summarizing the SNV and box plot of Ti and Tv in the E19del-subgroup (a and b) and in the SNV-subgroup (c and d). Mutational signature plot derived from a 74 X 96 matrix analyzed using the NMF, where 74 is the number of the study cohort (e) and bar graph indicating the degree to which each case contributed to the signature (f). *n.s. not significant. ** P-value was obtained by Wilcoxon signed rank test

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us